Global Alzheimer’s Disease Drug Market Status and Outlook 2018-2025

July 2018 | 151 pages | ID: GE62C9693EBEN
99Strategy

Abstracts

REPORT SNAPSHOT

Key Content of Chapters (Including and can be customized, report is a semifinished version, and it takes 48-72 hours to upgrade)

Part 1:
Terminology Definition, Industry Chain,Industry Dynamics & Regulations and Global Market Overview
Part 2:
Upstream (Raw Materials/Components) & Manufacturing (Procurement Methods & Channels and Cost), Major Regional Production Overview and Trade Flow
Part 3:
Product Segment Overview and Market Status
Part 4:
Application/End-User Segment Overview and Market Status
Part 5:
Region Segment Overview and Market Status
Part 6:
Product & Application Segment Production & Demand by Region
Part 7:
Market Forecast by Product, Application & Region
Part 8:
Company information, Products & Services and Business Operation (Sales, Cost, Margin etc.)
Part 9:
Market Competition and Environment for New Entrants
Part 10:
Conclusion

Market Segment as follows:

Key Companies

• Lundbeck.
• Merz Pharma
• Eisai
• Daiichi Sankyo
• Johnson & Johnson
• Novartis
• Allergan
• Pfizer

Market by Type

• Donepezil
• Memantine
• Rivastigmine

Market by Application

• Early to Moderate Stages
• Moderate to Severe Stages

Contents

PART 1 INDUSTRY OVERVIEW (200 USD)

1.1 Alzheimer’s Disease Drug Industry
  1.1.1 Market Development
  1.1.2 Terminology Definition in the Report
    1.1.2.1 Production
    1.1.2.2 Demand
    1.1.2.3 Sales Revenue
    1.1.2.4 Ex-factory Price & Sales Price
    1.1.2.5 Cost
    1.1.2.6 Gross Margin
1.2 Products & Services Scope
1.3 Industry Chain
1.4 Industry Dynamics & Regulations
1.5 Global Market Overview

PART 2 UPSTREAM & PRODUCTION (200 USD)

2.1 Raw Materials / Components
2.2 Procurement Methods & Channels
2.3 Cost Structure & Manufacturing
2.4 Industry Capacity
2.5 Production Distribution by Geography
  2.5.1 Production in Major Regions / Countries
  2.5.2 Trade Flow Overview

PART 3 PRODUCT SEGMENT (400 USD)

3.1 Introduction by Type
  3.1.1 Donepezil
  3.1.2 Memantine
  3.1.3 Rivastigmine
3.2 Market Status

PART 4 APPLICATION / END-USER SEGMENT (400 USD)

4.1 Introduction by Application
  4.1.1 Early to Moderate Stages
  4.1.2 Moderate to Severe Stages
4.2 Market Status

PART 5 REGIONAL MARKET (600 USD)

5.1 Market Overview
5.2 by Region
  5.2.1 North America
    5.2.1.1 United States Market Size and Growth (2015-2018E)
    5.2.1.2 Canada Market Size and Growth (2015-2018E)
    5.2.1.3 Mexico Market Size and Growth (2015-2018E)
  5.2.2 Europe
    5.2.2.1 Germany Market Size and Growth (2015-2018E)
    5.2.2.2 UK Market Size and Growth (2015-2018E)
    5.2.2.3 France Market Size and Growth (2015-2018E)
    5.2.2.4 Italy Market Size and Growth (2015-2018E)
    5.2.2.5 Spain Market Size and Growth (2015-2018E)
    5.2.2.6 Netherlands Market Size and Growth (2015-2018E)
    5.2.2.7 Poland Market Size and Growth (2015-2018E)
    5.2.2.8 Belgium Market Size and Growth (2015-2018E)
    5.2.2.9 Sweden Market Size and Growth (2015-2018E)
    5.2.2.10 Austria Market Size and Growth (2015-2018E)
    5.2.2.11 Denmark Market Size and Growth (2015-2018E)
    5.2.2.12 Switzerland Market Size and Growth (2015-2018E)
    5.2.2.13 Russia Market Size and Growth (2015-2018E)
  5.2.3 Asia-Pacific
    5.2.3.1 China Market Size and Growth (2015-2018E)
    5.2.3.2 India Market Size and Growth (2015-2018E)
    5.2.3.3 Japan Market Size and Growth (2015-2018E)
    5.2.3.4 Korea Market Size and Growth (2015-2018E)
    5.2.3.5 Australia Market Size and Growth (2015-2018E)
    5.2.3.6 Indonesia Market Size and Growth (2015-2018E)
    5.2.3.7 Thailand Market Size and Growth (2015-2018E)
    5.2.3.8 Malaysia Market Size and Growth (2015-2018E)
    5.2.3.9 Singapore Market Size and Growth (2015-2018E)
    5.2.3.10 Philippines Market Size and Growth (2015-2018E)
  5.2.4 South America
    5.2.4.1 Brazil Market Size and Growth (2015-2018E)
    5.2.4.2 Argentina Market Size and Growth (2015-2018E)
    5.2.4.3 Columbia Market Size and Growth (2015-2018E)
    5.2.4.4 Chile Market Size and Growth (2015-2018E)
    5.2.4.5 Peru Market Size and Growth (2015-2018E)
    5.2.4.6 Puerto Rico Market Size and Growth (2015-2018E)
    5.2.4.7 Ecuador Market Size and Growth (2015-2018E)
  5.2.5 Middle East
    5.2.5.1 Saudi Arabia Market Size and Growth (2015-2018E)
    5.2.5.2 Iran Market Size and Growth (2015-2018E)
    5.2.5.3 UAE Market Size and Growth (2015-2018E)
    5.2.5.4 Oman Market Size and Growth (2015-2018E)
    5.2.5.5 Kuwait Market Size and Growth (2015-2018E)
    5.2.5.6 Iraq Market Size and Growth (2015-2018E)
    5.2.5.7 Turkey Market Size and Growth (2015-2018E)
  5.2.6 Africa
    5.2.6.1 South Africa Market Size and Growth (2015-2018E)
    5.2.6.2 Egypt Market Size and Growth (2015-2018E)
    5.2.6.3 Nigeria Market Size and Growth (2015-2018E)
    5.2.6.4 Algeria Market Size and Growth (2015-2018E)
    5.2.6.5 Angola Market Size and Growth (2015-2018E)
    5.2.6.6 Morocco Market Size and Growth (2015-2018E)
    5.2.6.7 Sultan Market Size and Growth (2015-2018E)

PART 6 MARKET SUBDIVISION (800 USD)

6.1 Regional Production
  6.1.1 Production by Type
    6.1.1.1 Donepezil Production by Region
    6.1.1.2 Memantine Production by Region
    6.1.1.3 Rivastigmine Production by Region
  6.1.2 Production by Application
    6.1.2.1 Early to Moderate Stages Production by Region
    6.1.2.2 Moderate to Severe Stages Production by Region
6.2 Regional Demand
  6.2.1 Demand by Type
    6.2.1.1 Donepezil Demand by Region
    6.2.1.2 Memantine Demand by Region
    6.2.1.3 Rivastigmine Demand by Region
  6.2.2 Demand by Application
    6.2.2.1 Early to Moderate Stages Demand by Region
    6.2.2.2 Moderate to Severe Stages Demand by Region

PART 7 MARKET FORECAST (200 USD)

7.1 Global Forecast
7.2 Forecast by Type
7.3 Forecast by Application
7.4 Forecast by Region

PART 8 KEY COMPANIES LIST (600 USD)

8.1 Lundbeck.
  8.1.2 Company Information
  8.1.2 Products & Services
  8.1.3 Business Operation
8.2 Merz Pharma
  8.2.1 Company Information
  8.2.2 Products & Services
  8.2.3 Business Operation
8.3 Eisai
  8.3.1 Company Information
  8.3.2 Products & Services
  8.3.3 Business Operation
8.4 Daiichi Sankyo
  8.4.1 Company Information
  8.4.2 Products & Services
  8.4.3 Business Operation
8.5 Johnson & Johnson
  8.5.1 Company Information
  8.5.2 Products & Services
  8.5.3 Business Operation
8.6 Novartis
  8.6.1 Company Information
  8.6.2 Products & Services
  8.6.3 Business Operation
8.7 Allergan
  8.7.1 Company Information
  8.7.2 Products & Services
  8.7.3 Business Operation
8.8 Pfizer
  8.8.1 Company Information
  8.8.2 Products & Services
  8.8.3 Business Operation

PART 9 COMPANY COMPETITION (500 USD)

9.1 Market by Company
9.2 Price & Gross Margin
9.3 Competitive Environment for New Entrants
  9.3.1 Michael Porter's Five Forces Model
  9.3.2 SWOT

PART 10 RESEARCH CONCLUSION (100 USD)

List Of Tables

LIST OF TABLES

Table Alzheimer’s Disease Drug Industry Dynamics & Regulations List
Table Global Alzheimer’s Disease Drug Sales Revenue, Cost and Margin, 2015-2018E
Table Global Alzheimer’s Disease Drug Market Status by Type 2015-2018E, in USD Million
Table Global Alzheimer’s Disease Drug Market Status by Application 2015-2018E, in USD Million
Table Global Alzheimer’s Disease Drug Market Status by Application 2015-2018E, in Volume
Table Global Alzheimer’s Disease Drug Market by Region 2015-2018E, in USD Million
Table Global Alzheimer’s Disease Drug Market Share by Region in 2018, in USD Million
Table Global Alzheimer’s Disease Drug Market by Region 2015-2018E, in Volume
Table Global Alzheimer’s Disease Drug Market Share by Region in 2018, in Volume
Table Donepezil Production Value by Region 2015-2018E, in USD Million
Table Donepezil Production Volume by Region 2015-2018E, in Volume
Table Memantine Production Value by Region 2015-2018E, in USD Million
Table Memantine Production Volume by Region 2015-2018E, in Volume
Table Rivastigmine Production Value by Region 2015-2018E, in USD Million
Table Rivastigmine Production Volume by Region 2015-2018E, in Volume
Table Early to Moderate Stages Production Value by Region 2015-2018E, in USD Million
Table Early to Moderate Stages Production Volume by Region 2015-2018E, in Volume
Table Moderate to Severe Stages Production Value by Region 2015-2018E, in USD Million
Table Moderate to Severe Stages Production Volume by Region 2015-2018E, in Volume
Table Donepezil Market Size by Region 2015-2018E, in USD Million
Table Donepezil Market Size by Region 2015-2018E, in Volume
Table Memantine Market Size by Region 2015-2018E, in USD Million
Table Memantine Market Size by Region 2015-2018E, in Volume
Table Rivastigmine Market Size by Region 2015-2018E, in USD Million
Table Rivastigmine Market Size by Region 2015-2018E, in Volume
Table Early to Moderate Stages Market Size by Region 2015-2018E, in USD Million
Table Early to Moderate Stages Market Size by Region 2015-2018E, in Volume
Table Moderate to Severe Stages Market Size by Region 2015-2018E, in USD Million
Table Moderate to Severe Stages Market Size by Region 2015-2018E, in Volume
Table GlobalAlzheimer’s Disease Drug Forecast by Type 2019F-2025F, in USD Million
Table Alzheimer’s Disease Drug Forecast by Type 2019F-2025F, in Volume
Table Alzheimer’s Disease Drug Market Forecast by Application / End-User 2019F-2025F, in USD Million
Table Alzheimer’s Disease Drug Market Forecast by Application / End-User 2019F-2025F, in Volume
Table Alzheimer’s Disease Drug Market Forecast by Region 2019F-2025F, in USD Million
Table Alzheimer’s Disease Drug Market Forecast by Region 2019F-2025F, in Volume
Table Lundbeck. Information
Table Alzheimer’s Disease Drug Sales, Cost, Margin of Lundbeck.
Table Merz Pharma Information
Table Alzheimer’s Disease Drug Sales, Cost, Margin of Merz Pharma
Table Eisai Information
Table Alzheimer’s Disease Drug Sales, Cost, Margin of Eisai
Table Daiichi Sankyo Information
Table Alzheimer’s Disease Drug Sales, Cost, Margin of Daiichi Sankyo
Table Johnson & Johnson Information
Table Alzheimer’s Disease Drug Sales, Cost, Margin of Johnson & Johnson
Table Novartis Information
Table Alzheimer’s Disease Drug Sales, Cost, Margin of Novartis
Table Allergan Information
Table Alzheimer’s Disease Drug Sales, Cost, Margin of Allergan
Table Pfizer Information
Table Alzheimer’s Disease Drug Sales, Cost, Margin of Pfizer
Table Global Alzheimer’s Disease Drug Sales Revenue by Company 2015-2017, in USD Million
Table Global Alzheimer’s Disease Drug Sales Volume by Company 2015-2017, in Volume
Table Global Alzheimer’s Disease Drug Sales Volume by Company in 2018, in Volume

List Of Figures

LIST OF FIGURES

Figure Alzheimer’s Disease Drug Picture
Figure Alzheimer’s Disease Drug Industry Chain Diagram
Figure Global Alzheimer’s Disease Drug Sales Revenue 2015-2018E, in USD Million
Figure Global Alzheimer’s Disease Drug Sales Volume 2015-2018E, in Volume
Figure Global Alzheimer’s Disease Drug Market Status by Type 2015-2018E, in Volume
Figure North America Alzheimer’s Disease Drug Market Size and Growth 2015-2018E, in USD Million
Figure North America Alzheimer’s Disease Drug Market Size and Growth 2015-2018E, in Volume
Figure Europe Alzheimer’s Disease Drug Market Size and Growth 2015-2018E, in USD Million
Figure Europe Alzheimer’s Disease Drug Market Size and Growth 2015-2018E, in Volume
Figure Asia-Pacific Alzheimer’s Disease Drug Market Size and Growth 2015-2018E, in USD Million
Figure Asia-Pacific Alzheimer’s Disease Drug Market Size and Growth 2015-2018E, in Volume
Figure South America Alzheimer’s Disease Drug Market Size and Growth 2015-2018E, in USD Million
Figure South America Alzheimer’s Disease Drug Market Size and Growth 2015-2018E, in Volume
Figure Middle East Alzheimer’s Disease Drug Market Size and Growth 2015-2018E, in USD Million
Figure Middle East Alzheimer’s Disease Drug Market Size and Growth 2015-2018E, in Volume
Figure Africa Alzheimer’s Disease Drug Market Size and Growth 2015-2018E, in USD Million
Figure Africa Alzheimer’s Disease Drug Market Size and Growth 2015-2018E, in Volume
Figure Global Alzheimer’s Disease Drug Sales Revenue Forecast 2019F-2025F, in USD Million
Figure Global Alzheimer’s Disease Drug Sales Volume Forecast 2019F-2025F, in Volume
Figure Global Alzheimer’s Disease Drug Sales Price Forecast 2019F-2025F
Figure Global Alzheimer’s Disease Drug Gross Margin Forecast 2019F-2025F
Figure Global Alzheimer’s Disease Drug Sales Revenue by Company in 2018, in USD Million
Figure Global Alzheimer’s Disease Drug Price by Company in 2018
Figure Global Alzheimer’s Disease Drug Gross Margin by Company in 2018